• Categories
  • Archives

Brazil’s Health Council Wants Patents for Three AIDS Drugs Broken

Brazil’s National Health Council sent Thursday, August 11, a document to the Brazilian Minister of Health recommending he breaks the patents – by compulsory licensing – of three AIDS medications: Lopinavir/Ritonavir, known as Kaletra, Efavirenz, and Tenofovir.

The Brazilian government spends around US$ 335 million (800 million reais) on these drugs every year.


The resolution, which was approved unanimously by the 20 members of the Council, also advises breaking off negotiations with the pharmaceutical laboratories that manufacture these medications.


The Ministry has been trying to reach agreements with these companies for at least two years. A capsule of Kaletra currently costs Brazil US$ 1.17 (2.73 reais, at today’s exchange rate). If the drug were produced here, it would cost US$ 0.41 (0.95 reais).


The Council also proposes that local production be initiated. At present, Brazilian laboratories are already manufacturing eight types of anti-retroviral drugs.


These drugs, together with nine imported medications, are distributed to the six countries that have AIDS treatment agreements with Brazil: Cape Verde, Guinea-Bissau, São Tomé and Prí­ncipe, East Timor, Bolivia, and Paraguay.


The average annual cost per patient is around US$ 2,500. Brazil has 163,000 anti-retroviral users.


The authorization of compulsory licensing is permitted by Brazilian law when it is a question of health, nutrition, environmental defense, or the country’s technological or socioeconomic development.


According to the government, the right is guaranteed by Article 71 of the Brazilian Patent Law (9279/96), Executive Decrees 3201/99 and 4830/03, the international Trips Agreement (Agreement on Trade-Related Aspects of Intellectual Property Rights), and the Doha Declaration, which applies the Trips to matters of public health.


Agência Brasil

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Bargain Hunters Make Brazilian Market Rebound

Latin American shares turned higher, led by Brazilian receipts, which received the brunt of ...

Brazil’s Women Prisoners: Invisible and Wronged

Out of every 100 prisoners in the state of São Paulo, Brazil, 5 are ...

Soy Cultivation Is Bearing Slavery in Brazil, Says Report

The report "Eating the Amazon," released by the Greenpeace International non-government organization shows that, ...

Of Faith, Poverty and Beauty

The idea of staying indoors copying other people’s ideas just didn’t go over with ...

Brazil Can’t Make Its Mind on Transgenics

Marina Silva, Brazilian Minister of Environment is calling for a definitive ruling on transgenetic ...

Despite Crisis Brazil’s Textile Beats Ethanol Two to One in Revenue

Showing the world what textile goods Brazil produces – from fiber to clothes. That ...

Health Council Advises Brazil to Break Patent on Three AIDS Drugs

Brazil should break the patents on three HIV/AIDS drugs, whose cost could jeopardize national ...

A Washington State Worth of Jungle Becomes Sanctuary in Brazil

A large stretch of Brazilian Amazon rain forest almost the size of Uruguay or ...

After 12 Years of Debates Brazil Still Can’t Vote on Land Use Bill

Long after the clock had struck midnight, while in the middle of a heated ...

Despite Crisis Brazil & LatAm Neighbors Get US$ 139 Bi from Overseas, a 9% Boost

The global crisis doesn't seem to have affected direct foreign investments in Latin America ...